mifegyne
a. lapidot pharmaceuticals, ltd - mifepristone - tablets - mifepristone 200 mg - mifepristone - mifepristone - medical termination of developing intra-uterine pregnancy.- in sequential use with a prostaglandin analogue up to 63 days of amenorrhea.- softening and dilatation of the cervix uteri prior to surgical termination of pregnancy during the first trimester.- preparation for the action of prostaglandin analogues in the termination of pregnancy for medical reasons (beyond the first trimester).- labour induction in foetal death in utero.in patients where prostaglandin or oxytocin cannot be use.
cathejell with lidocaine
a.lapidot pharmaceuticals ltd, israel - chlorhexidine dihydrochloride; lidocaine hydrochloride - gel - lidocaine hydrochloride 2 %w/w; chlorhexidine dihydrochloride 0.05 %w/w - lidocaine - lidocaine - instillation into the urethra prior to the instillation of catheters or other instruments and manipulations which require the use of a local anesthetic.
ambica international corporation promeddazole metronidazole
akums drugs & pharmaceuticals ltd. (plant iii-injectables) - drug - metronidazole - promeddazole
norprolac 0.025 mg
ferring pharmaceuticals ltd - quinagolide as hydrochloride - tablets - quinagolide as hydrochloride 0.025 mg - quinagolide - quinagolide - second line treatment of hyperprolactinaemia (idiopathic or due to prolactin secreting micro- or macroadenoma) and its clinical manifestation (galactorrhoea, oligomenorrhea, infertility, reduced libido).
norprolac 0.05 mg
ferring pharmaceuticals ltd - quinagolide as hydrochloride - tablets - quinagolide as hydrochloride 0.05 mg - quinagolide - quinagolide - second line treatment of hyperprolactinaemia (idiopathic or due to prolactin secreting micro- or macroadenoma) and its clinical manifestation (galactorrhoea, oligomenorrhea, infertility, reduced libido).
norprolac 0.075 mg tablets
ferring pharmaceuticals ltd - quinagolide as hydrochloride - tablets - quinagolide as hydrochloride 0.075 mg - quinagolide - quinagolide - second line treatment of hyperprolactinaemia (idiopathic or due to prolactin secreting micro- or macroadenoma) and its clinical manifestation (galactorrhoea, oligomenorrhea, infertility, reduced libido).
norprolac 0.15 mg tablets
ferring pharmaceuticals ltd - quinagolide as hydrochloride - tablets - quinagolide as hydrochloride 0.15 mg - quinagolide - quinagolide - second line treatment of hyperprolactinaemia (idiopathic or due to prolactin secreting micro- or macroadenoma) and its clinical manifestation (galactorrhoea, oligomenorrhea, infertility, reduced libido).
sodium nitrite hope pharmaceuticals 30 mg/ml solution for injection
hope pharmaceuticals ltd - sodium nitrite - solution for injection - 30 milligram(s)/millilitre - sodium nitrite
sodium nitrite hope pharmaceuticals 30 mg/ml solution for injection
hope pharmaceuticals ltd - sodium nitrite - solution for injection - 30 milligram(s)/millilitre - sodium nitrite
sodium thiosulfate hope pharmaceuticals 250 mg/ml solution for injection
hope pharmaceuticals ltd - sodium thiosulfate - solution for injection - 250 milligram(s)/millilitre - antidotes; thiosulfate